228 related articles for article (PubMed ID: 25294380)
1. Visceral and somatic hypersensitivity, autonomic cardiovascular dysfunction and low-grade inflammation in a subset of irritable bowel syndrome patients.
Liu L; Liu BN; Chen S; Wang M; Liu Y; Zhang YL; Yao SK
J Zhejiang Univ Sci B; 2014 Oct; 15(10):907-14. PubMed ID: 25294380
[TBL] [Abstract][Full Text] [Related]
2. [Visceral sensitivity, gut barrier function and autonomic nerve function in patients with diarrhea-predominant irritable bowel syndrome].
Xu X; Liu L; Yao S; Zhang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 May; 42(5):522-528. PubMed ID: 28626097
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study.
Xu XJ; Zhang YL; Liu L; Pan L; Yao SK
Aliment Pharmacol Ther; 2017 Jan; 45(1):100-114. PubMed ID: 27862119
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
Zhang Y; Qin G; Liu DR; Wang Y; Yao SK
World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915
[TBL] [Abstract][Full Text] [Related]
5. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome.
Zhou Q; Zhang B; Verne GN
Pain; 2009 Nov; 146(1-2):41-6. PubMed ID: 19595511
[TBL] [Abstract][Full Text] [Related]
6. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
[TBL] [Abstract][Full Text] [Related]
8. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
[TBL] [Abstract][Full Text] [Related]
9. Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome.
Zhang WX; Zhang Y; Qin G; Li KM; Wei W; Li SY; Yao SK
World J Gastroenterol; 2019 Nov; 25(43):6416-6429. PubMed ID: 31798278
[TBL] [Abstract][Full Text] [Related]
10. Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial.
Edebol-Carlman H; Schrooten M; Ljótsson B; Boersma K; Linton S; Brummer RJ
Scand J Pain; 2018 Jan; 18(1):81-91. PubMed ID: 29794287
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.
Du C; Peng L; Kou G; Wang P; Lu L; Li Y
Dig Dis Sci; 2018 May; 63(5):1182-1191. PubMed ID: 29516326
[TBL] [Abstract][Full Text] [Related]
12. Autonomic response to a visceral stressor is dysregulated in irritable bowel syndrome and correlates with duration of disease.
Cheng P; Shih W; Alberto M; Presson AP; Licudine A; Mayer EA; Naliboff BD; Chang L
Neurogastroenterol Motil; 2013 Oct; 25(10):e650-9. PubMed ID: 23822743
[TBL] [Abstract][Full Text] [Related]
13. Abnormal endogenous pain modulation and somatic and visceral hypersensitivity in female patients with irritable bowel syndrome.
Wilder-Smith CH; Robert-Yap J
World J Gastroenterol; 2007 Jul; 13(27):3699-704. PubMed ID: 17659729
[TBL] [Abstract][Full Text] [Related]
14. Are characteristics of abdominal pain helpful to identify patients with visceral hypersensitivity in irritable bowel syndrome? Results of a prospective study.
Melchior C; Bril L; Leroi AM; Gourcerol G; Ducrotté P
Neurogastroenterol Motil; 2018 Jun; 30(6):e13290. PubMed ID: 29345401
[TBL] [Abstract][Full Text] [Related]
15. Relationships of abdominal pain, reports to visceral and temperature pain sensitivity, conditioned pain modulation, and heart rate variability in irritable bowel syndrome.
Jarrett ME; Han CJ; Cain KC; Burr RL; Shulman RJ; Barney PG; Naliboff BD; Zia J; Heitkemper MM
Neurogastroenterol Motil; 2016 Jul; 28(7):1094-103. PubMed ID: 26993039
[TBL] [Abstract][Full Text] [Related]
16. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine.
Kerckhoffs AP; ter Linde JJ; Akkermans LM; Samsom M
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1053-60. PubMed ID: 22323131
[TBL] [Abstract][Full Text] [Related]
17. Central and peripheral hypersensitivity in the irritable bowel syndrome.
Zhou Q; Fillingim RB; Riley JL; Malarkey WB; Verne NG
Pain; 2010 Mar; 148(3):454-461. PubMed ID: 20074857
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E
Grabauskas G; Wu X; Gao J; Li JY; Turgeon DK; Owyang C
Gastroenterology; 2020 Jun; 158(8):2195-2207.e6. PubMed ID: 32084424
[TBL] [Abstract][Full Text] [Related]
19. Viscerosomatic facilitation in a subset of IBS patients, an effect mediated by N-methyl-D-aspartate receptors.
Verne GN; Price DD; Callam CS; Zhang B; Peck J; Zhou Q
J Pain; 2012 Sep; 13(9):901-9. PubMed ID: 22958874
[TBL] [Abstract][Full Text] [Related]
20. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes.
Hughes PA; Harrington AM; Castro J; Liebregts T; Adam B; Grasby DJ; Isaacs NJ; Maldeniya L; Martin CM; Persson J; Andrews JM; Holtmann G; Blackshaw LA; Brierley SM
Gut; 2013 Oct; 62(10):1456-65. PubMed ID: 22767422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
